SCHEMBL7900869

SCHEMBL7900869

CC(C)(C)c1cc(Cc2cc(C(C)(C)C)cc(-n3nc4ccc(S(=O)(=O)c5ccccc5)cc4n3)c2O)c(O)c(-n2nc3ccc(S(=O)(=O)c4ccccc4)cc3n2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.37
POLB P06746 3/20 0.35
HSD11B1 P28845 2/20 0.35
BCL2 P10415 2/20 0.34
BCL2L1 Q07817 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGDR2 Q9Y5Y4 3/20 0.33
SRC P12931 2/20 0.32
HSD17B2 P37059 1/20 0.32
MCL1 Q07820 2/20 0.32
SIRT5 Q9NXA8 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTR6 P50406 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL769483 0.87 POLB (0.37) CNR2POLBHSD11B1NPC1RAB9A
SCHEMBL29357045 0.87 POLB (0.37) CNR2POLBHSD11B1NPC1RAB9A
SCHEMBL699155 0.83 NPC1 (0.47) POLBNPC1RAB9AMAPTALDH1A1
SCHEMBL5669041 0.83 NPC1 (0.44) CNR2POLBHSD11B1NPC1RAB9A
SCHEMBL8351052 0.81 POLB (0.35) POLBNPC1RAB9AMEN1USP2
SCHEMBL9263512 0.80 NR1I2 (0.36) POLBHSD11B1NPC1RAB9AMAPT
SCHEMBL21586972 0.80 POLB (0.37) CNR2POLBHSD11B1NPC1RAB9A
SCHEMBL5834568 0.79 POLB (0.35) CNR2POLBHSD11B1NPC1RAB9A
SCHEMBL21586956 0.79 POLB (0.46) CNR2POLBHSD11B1NPC1RAB9A
SCHEMBL30397522 0.79 POLB (0.46) CNR2POLBHSD11B1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010011113-A1 Asymmertical bisbenzotriazoles substituted by a perfluoroalkyl moiety and compositions stabilized therewith WOOD MERVIN (US) 2001-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010011113-A1 Asymmertical bisbenzotriazoles substituted by a perfluoroalkyl moiety and compositions stabilized therewith FLNA, FLNB, PFAS CNR2 2775/4885POLB 1843/4885HSD11B1 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.